Indy Star interviewed Thomas F. Imperiale, M.D., about his study published in the New England Journal of Medicine. This next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers and has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
-
Research
- Experts
In The News
View AllMedical Xpress features Dr. Alexia Torke
Alexia M. Torke, M.D., M.S., was featured by Medical Xpress...
Influence
View AllPredicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling
Published in the Alzheimer’s & Dementia: The Journal of the...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
March 19, 2024
Indy Star interviewed Dr. Thomas F. Imperiale

"*" indicates required fields